Disease management
Also, health IT company UCrest from Malaysia has received its first patent for its AI-powered digital platform from Taiwan.
The company will use the funds to drive commercial growth, broaden its employer and payer programs, and accelerate AI development.
Data from the study revealed that chronic exposure to cortisol disrupts neuronal network activity and damages long-term potentiation, simulating stress-related cognitive decline.
The two companies will develop affordable peptide therapies aimed at extending women’s lifespan.
The company received an additional equity investment from OrbiMed.
Developed with Murdoch Children's Research Institute, the AI has shown 90% detection accuracy.
The deep multi-task learning AI analyses X-ray images of premature babies to identify intestinal perforation and its location.
Developed at the University of South Australia, it could help doctors safely deprescribe obsolete medications.
PKG Health's movement disorder algorithms and digital endpoints will be integrated into Empatica’s AI-enabled health monitoring wearables.
The company will use the funds to develop AI capabilities and move into weight loss, cardiometabolic care, diabetes, thyroid disorders and cardiovascular disease.